Filing Details
- Accession Number:
- 0001415889-24-029377
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-13 19:53:20
- Reporting Period:
- 2024-12-12
- Accepted Time:
- 2024-12-13 19:53:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1671858 | Ars Pharmaceuticals Inc. | SPRY | Pharmaceutical Preparations (2834) | 811489190 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1951238 | Justin Chakma | C/O Ars Pharmaceuticals, Inc. 11682 El Camino Real, Suite 120 San Diego CA 92130 | Chief Business Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-12-12 | 117,333 | $0.84 | 253,713 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-12-12 | 117,333 | $12.27 | 136,380 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-12-13 | 27,272 | $1.44 | 163,652 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-12-13 | 27,272 | $12.06 | 136,380 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-12-12 | 117,333 | $0.00 | 117,333 | $0.84 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-12-13 | 27,272 | $0.00 | 27,272 | $1.44 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 119,047 | 2029-07-04 | No | 4 | M | Direct | |
| 55,461 | 2031-12-13 | No | 4 | M | Direct |
Footnotes
- The weighted average sale price for the transaction reported was $12.2653, and the range of prices were between $11.83 and $12.67. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
- The weighted average sale price for the transaction reported was $12.0625, and the range of prices were between $11.83 and $12.28. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
- Immediately exercisable.
Billionaire Hedge Funds
